Related Experiment Video

Updated: Jul 5, 2026

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration
11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

Selective blockade of T-type Ca2+ channels suppresses human breast cancer cell proliferation

James T Taylor1, Luping Huang, Jonathan E Pottle

  • 1Department of Pharmacology, Tulane University Health Sciences Center, New Orleans, LA 70112, USA.

Cancer Letters
|May 6, 2008
PubMed

Insights

T-type calcium channels (Ca2+) are expressed in breast cancer cells and drive proliferation. Inhibiting or silencing these channels significantly reduces cancer cell growth, suggesting a therapeutic target.

Area of Science:

  • Molecular Biology
  • Oncology
  • Cell Physiology

Background:

  • T-type calcium channels (Ca2+) play roles in cell proliferation and are implicated in various cancers.
  • Understanding their specific role in breast cancer is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the expression and function of T-type Ca2+ channels in breast cancer cell lines.
  • To determine the effect of T-type Ca2+ channel inhibition on breast cancer cell proliferation.

Main Methods:

  • Quantitative real-time PCR (Q-RT-PCR) and Western blot to measure T-type Ca2+ channel mRNA and protein expression.
  • Treatment with a selective T-type Ca2+ channel inhibitor (NNC-55-0396) and siRNA-mediated gene silencing.
  • Cellular proliferation assays on MCF-7 (ERalpha+) and MCF-10A cell lines.

Main Results:

  • MCF-7 cells express alpha1G and alpha1H isoforms of T-type Ca2+ channels.
  • Inhibition of T-type Ca2+ channels significantly reduced MCF-7 cell proliferation, but not MCF-10A cells.
  • T-type Ca2+ channel expression was higher in rapidly growing, non-confluent cells compared to confluent cells.
  • siRNA-mediated knockdown of T-type Ca2+ channels resulted in a 45%+/-5.0 reduction in MCF-7 cell growth.

Conclusions:

  • T-type Ca2+ channels are expressed in breast cancer cells and contribute to their proliferation.
  • Antagonism or silencing of T-type Ca2+ channels shows potential for reducing breast cancer cell proliferation.
  • Targeting T-type Ca2+ channels may represent a novel therapeutic strategy for breast cancer.

More Related Videos

Utilization of the Soft Agar Colony Formation Assay to Identify Inhibitors of Tumorigenicity in Breast Cancer Cells11:06

Utilization of the Soft Agar Colony Formation Assay to Identify Inhibitors of Tumorigenicity in Breast Cancer Cells

Published on: May 20, 2015

Isolation and Functional Assessment of Human Breast Cancer Stem Cells from Cell and Tissue Samples07:03

Isolation and Functional Assessment of Human Breast Cancer Stem Cells from Cell and Tissue Samples

Published on: October 2, 2020

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...